# A Phase Ⅱa Clinical Study of CL-197 Capsules

> **NCT07308782** · PHASE2 · RECRUITING · sponsor: **Henan Genuine Biotech Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** CL-197 capsules

## Key facts

- **NCT ID:** NCT07308782
- **Lead sponsor:** Henan Genuine Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-29
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07308782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07308782, "A Phase Ⅱa Clinical Study of CL-197 Capsules". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07308782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*